Targeting Purinergic Receptor P2RX1 Modulates Intestinal Microbiota and Alleviates Inflammation in Colitis

Inflammatory bowel disease (IBD) remains one of the most prevalent gastrointestinal diseases worldwide. Purinergic signaling has emerged as a promising therapeutic target of inflammation-associated diseases. However, little is known about the specific roles of purinergic receptors in IBD. In the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xu, Yuan, Xiao, Su, Yuting, Hu, Jing, Ji, Qian, Fu, Shengqiao, Li, Rongkun, Hu, Lipeng, Dai, Chunhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329583/
https://www.ncbi.nlm.nih.gov/pubmed/34354708
http://dx.doi.org/10.3389/fimmu.2021.696766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329583/
https://www.ncbi.nlm.nih.gov/pubmed/34354708
http://dx.doi.org/10.3389/fimmu.2021.696766

Ejemplares similares